HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany

Autor:	L Frick, Z Qiu, M Schönermark
Rok vydání:	2022
Předmět:	Health Policy Public Health Environmental and Occupational Health
Zdroj:	Value in Health. 25:S305
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::ba933681c39a399bc2d2f037ac13c7eb https://doi.org/10.1016/j.jval.2022.09.1506 Zobrazit plný text záznamu Full Text from ScienceDirect